Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Generalized Anxiety Disorder Market Growth From $8.18 Billion In 2026 To $9.72 Billion By 2030 At A CAGR Of 4.4%
The generalized anxiety disorder market size has shown consistent growth over recent years. It is projected to expand from $7.93 billion in 2025 to $8.18 billion in 2026, achieving a compound annual growth rate (CAGR) of 3.2%. The historical increase can be attributed to several factors including rising mental health awareness, the widespread availability of antidepressants, the expansion of psychiatric services, prevailing societal stress factors, and advancements in primary care diagnosis.
The market for generalized anxiety disorder is projected to experience consistent expansion over the upcoming years. This market is anticipated to reach $9.72 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 4.4%. Factors contributing to this growth trajectory during the projection period include the rise of digital therapeutics, the escalating demand for tailored mental healthcare solutions, a surge in telehealth utilization, an emphasis on proactive mental well-being, and advancements in neuromodulation treatments. Key trends anticipated within the forecast timeframe encompass the growing acceptance of cognitive behavioral therapy, a heightened reliance on pharmaceutical treatments for anxiety, the proliferation of digital platforms for mental health, the broadening scope of remote and telepsychiatry offerings, and an enhanced public understanding of mental health conditions.
Get A Free Sample Report With In-Depth Market Insights:
Generalized Anxiety Disorder Market Development Factors: What’s Supporting Demand?
The increasing incidence of mental disorder cases within the healthcare industry is fueling the growth of the generalized anxiety disorder market. A mental disorder, alternatively termed a mental illness, encompasses a broad spectrum of conditions that impact an individual’s thoughts, emotions, behaviors, and overall mental well-being. Mental health disorders commonly observed alongside generalized anxiety disorder include phobias, panic disorder, post-traumatic stress disorder (PTSD), and obsessive-compulsive disorder (OCD), and effectively managing these conditions is vital for individuals to sustain healthy relationships and improve their quality of life. For instance, in November 2023, according to the Stress in America 2023 survey published by American Psychological Association, a US-based professional organization, adults aged 35 to 44 experienced the most significant rise in mental health diagnoses, with 45% reporting a mental illness in 2023 compared with 31%. However, adults ages 18 to 34 still reported the highest rate of mental illnesses at 50% in 2023. Consequently, the rising number of mental disorder cases is expected to propel the growth of the generalized anxiety disorder market.
Generalized Anxiety Disorder Market Segment Landscape: Which Areas Lead Development?
The generalized anxiety disorder market covered in this report is segmented –
1) By Type: Panic Disorder, Agoraphobia, Generalized Anxiety, Social Anxiety, Specific Phobia, Other Types
2) By Therapies: Interpersonal Therapy, Behavior Therapy, Cognitive Behavioral Therapy, Mindfulness Based Cognitive Therapy
3) By Device: Deep Brain Stimulation, Electroconvulsive Therapy, Transcranial Magnetic Stimulation, Vagus Nerve Stimulation
4) By End-User: Hospitals, Homecare, Specialty Clinics, Other End-Users
Subsegments:
1) By Panic Disorder: Recurrent Panic Attacks, Unexpected Panic Attacks
2) By Agoraphobia: Situational Phobia, Open Spaces Anxiety
3) By Generalized Anxiety: Chronic Worry, Excessive Anxiety
4) By Social Anxiety: Performance Anxiety, Interaction Anxiety
5) By Specific Phobia: Animal Phobia, Environmental Phobia, Situational Phobia
6) By Other Type: Separation Anxiety Disorder, Selective Mutism, Post-Traumatic Stress Disorder (PTSD)
Generalized Anxiety Disorder Market Trends Powering Strategic Industry Growth
Major companies operating within the generalized anxiety disorder market are actively developing innovative drugs, such as MM-120, and securing approvals for the treatment of generalized anxiety disorder to more effectively cater to their existing consumers. Novel medications like MM-120 are designed to improve the management and results associated with this mental health condition. For instance, in September 2023, Mind Medicine Inc. (MindMed), a U.S.-based biotech company focused on psychedelic-inspired therapies, finalized the enrollment process for its Phase 2b trial of MM 120 (lysergide D-tartrate) intended for generalized anxiety disorder (GAD). With this significant achievement, MindMed aims to generate comprehensive efficacy and safety data to facilitate the continued development of MM 120 as a new therapeutic option for GAD. MM 120 functions as a small-molecule partial agonist of the 5 HT2A receptor, formulated to enhance neuroplasticity and serotonin signaling to improve mood and anxiety, and it exhibited a dose-dependent reduction in anxiety symptoms during the trial.
Generalized Anxiety Disorder Market Industry Leaders And Competitive Landscape
Major companies operating in the generalized anxiety disorder market are Alkermes plc, Pfizer Inc., F. Hoffmann-La Roche AG, Sanofi SA, Bristol-Myers Squibb, GlaxoSmithKline plc, Johnson And Johnson Private Limited, Teva Pharmaceutical Industries Ltd., Otsuka Holdings Co. Ltd., Mylan N.V., Sumitomo Pharma Co. Ltd., Forest Laboratories Inc., H. Lundbeck A/S, Neurocrine Biosciences Inc., Actavis Pharmaceutical Company, Eli Lilly and Company, Mind Medicine Inc., Sage Therapeutics Inc., VistaGen Therapeutics Inc.
View The Full Generalized Anxiety Disorder Market Report:
Generalized Anxiety Disorder Market Geographic Analysis: Where Is Demand Rising Fastest?
North America was the largest region in the generalized anxiety disorder market in 2025. The regions covered in the generalized anxiety disorder market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
